Dyslipidemias

29 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Dyslipidemias
Treatment and conditionWhere it standsTrials
Autoinjector + EVOLOCUMAB for hypercholesterolemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Autoinjector + EVOLOCUMAB for hyperlipoproteinemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Barley beta-glucan(3.0g) for hyperlipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Control for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for homozygous familial hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for hyperlipoproteinemia type vPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
DR10624 Injection for hypertriglyceridemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Enlicitide for hypercholesterolemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide for hyperlipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Chloride for hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Decanoate for hypercholesterolemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Enlicitide Decanoate for hyperlipoproteinemia type iiPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Evolocumab for hypercholesterolemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Exercise for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ezetimibe or ezetimibe-statin combination therapy for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fixed-Dose Combination Strategy for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity Mediterranean diet intervention for hyperlipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inclisiran for hyperlipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Laroprovstat for dyslipidemiasPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MAR001 for hypertriglyceridemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
obicetrapib 10 mg + ezetimibe 10 mg FDC daily for hyperlipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Olezarsen for hyperlipoproteinemia type iPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for hyperlipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
SHR-1918 for homozygous familial hypercholesterolemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for dyslipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for hypercholesterolemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for hyperlipoproteinemia type iiPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1